These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 3594435)

  • 1. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.
    Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
    Anticancer Res; 1994; 14(6B):2573-6. PubMed ID: 7872683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in mice.
    Manda T; Nishigaki F; Mori J; Shimomura K
    Cancer Res; 1988 Aug; 48(15):4250-5. PubMed ID: 3390820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the toxicity of tumor necrosis factor by tumors in mice.
    Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
    Circ Shock; 1994 Oct; 44(2):77-83. PubMed ID: 7743604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors.
    Nakamura S; Nakata K; Kashimoto S; Yoshida H; Yamada M
    Jpn J Cancer Res; 1986 Aug; 77(8):767-73. PubMed ID: 3093425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
    Gatanaga T; Noguchi K; Tanabe Y; Inagawa H; Soma G; Mizuno D
    J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
    Inagawa H; Oshima H; Soma G; Mizuno D
    J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
    Asher A; Mulé JJ; Reichert CM; Shiloni E; Rosenberg SA
    J Immunol; 1987 Feb; 138(3):963-74. PubMed ID: 3805720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
    Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
    J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor.
    Creasey AA; Reynolds MT; Laird W
    Cancer Res; 1986 Nov; 46(11):5687-90. PubMed ID: 3756916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid tumor regression caused by antitumor polysaccharide and induction of tumor-regressing factor in the serum of tumor-bearing mice.
    Kunimoto T; Baba H; Nitta K
    J Biol Response Mod; 1986 Apr; 5(2):160-7. PubMed ID: 3734842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system.
    Inagawa H; Nishizawa T; Noguchi K; Minamimura M; Takagi K; Goto S; Soma G; Mizuno D
    Anticancer Res; 1997; 17(3C):2153-8. PubMed ID: 9216680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.
    Noguchi K; Inagawa H; Tsuji Y; Morikawa A; Mizuno D; Soma G
    J Immunother (1991); 1991 Apr; 10(2):105-11. PubMed ID: 2043590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
    Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
    Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
    Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of recombinant tumor necrosis factor in cancer patients.
    Blick M; Sherwin SA; Rosenblum M; Gutterman J
    Cancer Res; 1987 Jun; 47(11):2986-9. PubMed ID: 3567916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of recombinant human interferon-alpha A/D on the growth of experimental tumors in mice].
    Ootsu K; Kozai Y; Houkan T; Gotoh K; Matsutani E
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2502-8. PubMed ID: 3304169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.